Prospective Intestinal Ultrasound Study for Artificial Intelligence Algorithm Development

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of British Columbia

About this trial

This observational study will use intestinal ultrasound images to help develop computer programs that may make it easier to assess bowel inflammation.

The study will include adults who are healthy or who are having an intestinal ultrasound as part of care for inflammatory bowel disease, such as Crohn disease or ulcerative colitis. Researchers want to find out whether a computer program can measure bowel wall thickness from ultrasound images as accurately as experienced ultrasound clinicians. They will also explore whether the program can identify other changes in the bowel.

Participants will have an intestinal ultrasound as part of their usual care. People who agree to take part will allow the research team to use de-identified ultrasound images and a small amount of related health information. No medication, experimental treatment, or additional ultrasound procedure will be given for this study. The computer program will not be used to make decisions about a participant's care, and participants will not receive individual results from the program.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adults aged 18 years or older.

Individuals who are either healthy with no known finding of inflammatory bowel disease before the ultrasound examination or undergoing intestinal ultrasound for inflammatory bowel disease screening, monitoring, or another clinical reason.

Individuals who are able and willing to provide informed consent for the collection and use of de-identified study data.

Disqualifiers

Individuals who do not meet the study demographic requirements.

Individuals unable or unwilling to provide informed consent.

Pregnant individuals.

Individuals with health conditions managed using drugs or medical-device intervention, or with unmanaged conditions or conditions requiring monitoring, that could affect study eligibility or the ultrasound assessment.

Trial population

The study population will consist of adults aged 18 years and older who are either healthy or undergoing intestinal ultrasound for inflammatory bowel disease screening, monitoring, or another clinical reason. Participants will be recruited through the IBD Centre of BC and other participating study sites. The study may include individuals with inflammatory bowel disease and healthy volunteers. The study aims to include a diverse participant population to support evaluation of artificial intelligence algorithm performance across different participant characteristics.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • De-identified Intestinal Ultrasound Data Collection

    Other intervention

    Intestinal ultrasound images and cine loops will be collected from adults undergoing ultrasound as part of routine clinical care. Following informed consent, the images and cine loops will be de-identified and used for artificial intelligence algorithm development, training, tuning, and testing. The study does not assign participants to receive an intervention, and the ultrasound is not performed solely for research purposes. The artificial intelligence algorithms developed using the data will not be used to guide participant care or provide individual diagnostic results during the study.

Treatment groups

95 Participants
are divided into 1 treatment group
Group A: Intestinal Ultrasound Participants1 intervention

Trial outcomes

Primary outcomes

1

Artificial Intelligence-Generated Bowel Wall Thickness Measurement Agreement

Agreement between bowel wall thickness measurements generated by the artificial intelligence computer-vision algorithm and manual bowel wall thickness measurements performed by experienced sonographers using de-identified intestinal ultrasound images and cine loops. Agreement will be assessed using the pre-specified performance metric in the statistical analysis plan.

Time frame
Day 1, after completion of the intestinal ultrasound examination

Secondary outcomes

1

Bowel Wall Layer Stratification Feasibility

Proportion of de-identified intestinal ultrasound images and cine loops for which the artificial intelligence algorithm generates an interpretable bowel wall layer stratification.

Time frame
Day 1, after completion of the intestinal ultrasound examination
2

Luminal Diameter Measurement Feasibility

Proportion of de-identified intestinal ultrasound images and cine loops for which the artificial intelligence algorithm generates an interpretable luminal diameter measurement.

Time frame
Day 1, after completion of the intestinal ultrasound examination
3

Bowel Wall Flow Assessment Feasibility

Proportion of de-identified intestinal ultrasound images and cine loops for which the artificial intelligence algorithm generates an interpretable bowel wall flow assessment.

Time frame
Day 1, after completion of the intestinal ultrasound examination
4

Bowel Wall Scarring Assessment Feasibility

Proportion of de-identified intestinal ultrasound images and cine loops for which the artificial intelligence algorithm generates an interpretable bowel wall scarring assessment.

Time frame
Day 1, after completion of the intestinal ultrasound examination

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of British Columbia

Lead sponsor

IBD Centre of BC

Collaborator

Providence Health Care Ventures

Collaborator

Dova Health Intelligence Inc

Collaborator

This trial is not recruiting at the moment. You can still explore other options: